0 Комментарии
0 Поделились
295 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Generic Oncology Drug Market – Manufacturing Capacity and Global Supply Chain ResilienceMarket Overview The generic oncology drug market depends heavily on robust manufacturing infrastructure capable of producing complex chemotherapy and targeted therapy formulations at consistent quality and sufficient scale to meet rising global demand. Supply chain disruptions affecting oncology drug availability can have serious consequences for patient care, making manufacturing resilience a...0 Комментарии 0 Поделились 64 Просмотры 0 предпросмотр
-
Global Cancer Immunotherapy Market Expands with Rising Demand for Precision Oncology TreatmentsCancer Immunotherapy Market Expands Rapidly as Precision Oncology and Advanced Biologic Therapies Transform Cancer Treatment Overview The Global Cancer Immunotherapy Market is witnessing substantial growth as healthcare providers, pharmaceutical companies, and research institutions increasingly focus on advanced immune-based therapies to improve cancer treatment outcomes. Cancer...0 Комментарии 0 Поделились 552 Просмотры 0 предпросмотр
-
Global JAK2 Inhibitor Market Forecast: Emerging Opportunities Across Oncology and Hematology Applications" According to the latest report published by Data Bridge Market Research, the JAK2 Inhibitor Market CAGR Value Global JAK2 Inhibitor market size was valued at USD 4.32 billion in 2024 and is projected to reach USD 10.12 billion by 2032, with a CAGR of 11.2% during the forecast period of 2025 to 2032. The supreme JAK2 Inhibitor Market research report has been built by skilful and...0 Комментарии 0 Поделились 262 Просмотры 0 предпросмотр
-
Global Oncology Biosimilars Market Forecast to 2031: Growth Opportunities, and Future OutlookThe global Oncology Biosimilars Market is witnessing significant expansion, driven by the increasing burden of cancer and the need for cost-effective biologic therapies. The market is expected to reach US$ 26,618 million by 2031, registering a robust CAGR of 16.3% during 2025–2031. This strong growth reflects the rising adoption of biosimilars as viable alternatives to expensive biologic...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Global Oncology Biosimilars Market to Grow from US$ 3.33 Billion to US$ 5.57 Billion by 2029 at a 7.61% CAGRGlobal Oncology Biosimilars Market to Grow from US$ 3.33 Billion to US$ 5.57 Billion by 2029 at a 7.61% CAGR The Global Oncology Biosimilars Market is entering a new phase of sustainable expansion as precision medicine, biotechnology innovation, AI-driven healthcare, and patient-centric cancer treatment continue transforming global oncology. According to Maximize...0 Комментарии 0 Поделились 211 Просмотры 0 предпросмотр
-
Global Oncology Nutrition Market Forecast and Competitive Analysis 2031Cancer treatment can significantly affect patients' nutritional status through appetite loss, nausea, metabolic changes, swallowing difficulties, and treatment-related side effects. Specialized nutritional support is therefore becoming an important component of comprehensive cancer care. The Oncology Nutrition Market is projected to grow from US$2.23 billion in 2024 to US$3.68 billion by 2031,...0 Комментарии 0 Поделились 111 Просмотры 0 предпросмотр
-
Global Oncology Patient Management Software Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033" According to the latest report published by Data Bridge Market Research, the Oncology Patient Management Software Market The global Oncology Patient Management Software Market size was valued at USD 6.25 billion in 2025 and is expected to reach USD 13.20 billion by 2033, at a CAGR of 9.8% during the forecast period The market growth is primarily driven by...0 Комментарии 0 Поделились 729 Просмотры 0 предпросмотр
-
Global Pharmaceutical Grade Cabazitaxel Market Forecast 2034: Oncology Demand, Growth Drivers, and Competitive InsightsGlobal Pharmaceutical Grade Cabazitaxel market was valued at USD 312 million in 2025 and is projected to reach USD 440 million by 2034, exhibiting a steady compound annual growth rate (CAGR) of 5.2% during the forecast period. Pharmaceutical Grade Cabazitaxel is a high-purity, semi-synthetic taxane derivative specifically engineered for oncology applications. As a microtubule...0 Комментарии 0 Поделились 224 Просмотры 0 предпросмотр
-
Global Uterine Carcinosarcoma Market Advances with Growing Focus on Targeted Therapies and Precision OncologyAccording to the latest report published by Data Bridge Market Research, the Uterine Carcinosarcoma Market CAGR Value This Uterine Carcinosarcoma Market research report is one of the unmatched and comprehensive market research reports which emphasize the challenges, market structures, opportunities, driving forces, emerging trends, and competitive landscape of Uterine...0 Комментарии 0 Поделились 284 Просмотры 0 предпросмотр
-
How Advancements in Oncology Are Driving the Global Anal Cancer MarketThe growing need for early diagnosis, effective treatment, and improved patient outcomes is driving attention toward therapies and healthcare solutions designed to address anal cancer. Increasing awareness of cancer screening, advances in diagnostic technologies, and expanding access to specialized oncology care are supporting the adoption of innovative treatment approaches. Continued research...0 Комментарии 0 Поделились 215 Просмотры 0 предпросмотр
-
How Precision Oncology, Advanced Imaging, and Minimally Invasive Treatments Are Transforming the Global Eye Cancer Treatment MarketThe eye cancer treatment market is expanding as healthcare providers improve early diagnosis, specialist oncology care, ophthalmic imaging, and access to targeted therapies. The market was valued at USD 2.02 billion in 2024 and is projected to reach USD 4.5 billion by 2035, growing at a CAGR of 7.6%. 1207 The Eye Cancer Treatment Market includes radiation therapy, chemotherapy, surgery,...0 Комментарии 0 Поделились 80 Просмотры 0 предпросмотр
-
Dasatinib Market Growth in Emerging Healthcare MarketsThe global Dasatinib Market was valued at USD 5.6 billion in 2025 and is projected to reach USD 7.6 billion by 2033, expanding at a CAGR of 4.3% from 2026 to 2033. The market is witnessing steady growth due to the increasing prevalence of hematologic cancers, particularly Chronic Myeloid Leukemia (CML) and Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL)....0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Radiation Oncology Market Insights for Investors and BusinessesThe global Radiation Oncology Market was valued at USD 14.0 billion in 2025 and is projected to grow from USD 15.5 billion in 2026 to USD 33.1 billion by 2033, registering a CAGR of 11.4% from 2026 to 2033. North America accounted for the largest revenue share of 46.2% in 2025, driven by the increasing prevalence of cancer, continuous technological advancements, and growing demand for...0 Комментарии 0 Поделились 655 Просмотры 0 предпросмотр
-
Basal Cell Carcinoma Therapeutics Market to Reach USD 14.6 Billion by 2032 | CAGR 7.3%According to a newly published market research report by 24LifeSciences, global basal cell carcinoma therapeutics market was valued at USD 8.2 billion in 2024 and is projected to reach USD 14.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025-2032. Basal Cell Carcinoma (BCC), the most common form of skin cancer accounting for...0 Комментарии 0 Поделились 5Кб Просмотры 0 предпросмотр
-
Blood Cancer Market Size and Revenue Forecast to 2032According to the latest report published by Data Bridge Market Research, the Blood Cancer Market Global blood cancer market size was valued at USD 57.23 billion in 2024 and is projected to reach USD 117.43 billion by 2032, with a CAGR of 9.40% during the forecast period of 2025 to 2032. With the effectual use of technology, innovative applications and expertise, Blood Cancer Market...0 Комментарии 0 Поделились 12Кб Просмотры 0 предпросмотр
-
Breast Cancer Drugs Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2030According to the latest report published by Data Bridge Market Research, the Breast Cancer Drugs Market Data Bridge Market Research analyzes that the global breast cancer drugs market is expected to reach USD 55,996.57 million by 2030 from USD 30,247.54 million in 2022, growing at a CAGR of 8.2% during the forecast period of 2023 to 2030. All the statistical data including...0 Комментарии 0 Поделились 9Кб Просмотры 0 предпросмотр
-
Cytotoxic Drugs Market Size, Share, Trends & Forecast to 2032According to the latest report published by Data Bridge Market Research, the Cytotoxic Drugs Market Global cytotoxic drugs market size was valued at USD 17.59 billion in 2024 and is projected to reach USD 42.11 billion by 2032, with a CAGR of 7.5% during the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate,...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
Gamma Probe Device Market Size, Share, and Growth Forecast to 2029According to the latest report published by Data Bridge Market Research, the Gamma Probe Device Market Data Bridge Market Research analyses that the gamma probe device market is expected to grow at a CAGR of 8.00% during the forecast period. “Mobile Devices” accounts for the largest modality segment in the gamma probe device market, owning continuous product development...0 Комментарии 0 Поделились 8Кб Просмотры 0 предпросмотр
-
GVHD Treatment Market to Reach USD 2.1 Billion by 2031 | CAGR 8.5%According to a newly published market research report by 24LifeSciences, global Graft Versus Host Disease (GVHD) Treatment market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.5% during the forecast period 20252031. Graft versus Host Disease, a serious complication following stem cell or bone...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Hematology Oncology Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033According to the latest report published by Data Bridge Market Research, the Hematology Oncology Market The global hematology oncology market size was valued at USD 10.98 billion in 2025 and is expected to reach USD 20.02 billion by 2033, at a CAGR of 7.80% during the forecast period The wide ranging Hematology Oncology Market report provides an overview...0 Комментарии 0 Поделились 8Кб Просмотры 0 предпросмотр
-
Linear Particle Accelerators Industry Size and Forecast Analysis to 2033According to the latest report published by Data Bridge Market Research, the Linear Particle Accelerators Market The global linear particle accelerators market size was valued at USD 3.09 billion in 2025 and is expected to reach USD 4.83 billion by 2033, at a CAGR of 5.76% during the forecast period The winning Linear Particle Accelerators...0 Комментарии 0 Поделились 8Кб Просмотры 0 предпросмотр
-
Liquid Biopsy Tests Market Size and Revenue Forecast to 2033According to the latest report published by Data Bridge Market Research, the Liquid Biopsy Tests Market The global liquid biopsy tests market size was valued at USD 673.2 Million in 2025 and is expected to reach USD 2347.79 Million by 2033, at a CAGR of 16.90% during the forecast period For generating the Liquid Biopsy Tests Market document;...0 Комментарии 0 Поделились 9Кб Просмотры 0 предпросмотр
-
Medical Linear Accelerator Industry Size and Forecast Analysis to 2032According to the latest report published by Data Bridge Market Research, the Medical Linear Accelerator Market The global medical linear accelerator market was valued at USD 3.90 billion in 2024 and is expected to reach USD 3.90 billion by 2032 During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 7.10%, primarily driven by the...0 Комментарии 0 Поделились 9Кб Просмотры 0 предпросмотр
Расширенные страницы
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek
Bengali